Progress for glucocorticoid in prevention and treatment of bronchopulmonary dysplasia in premature infants / 国际儿科学杂志

Bronchopulmonary dysplasia (BPD) is one of the common respiratory diseases in premature infants.Recently,the survival rate of VLBW and ELBW infants is increasing,and the incidence of BPD is also increasing year by year.However,the treatment of BPD still lacks a unified clinical standard.The main treatments include permissive hypercapnia,glucocorticoid,bronchiectator,caffeine and inhaled nitric oxide.The treatment of glucocorticoids,including systemic and local medication,is the focus of clinical research.How to use hormones rationally to prevent and treat BPD and minimize adverse reactions is a hot issue.